Focus Taiwan App

Academia Sinica, Moderna to cooperate on mRNA research

06/01/2023 06:10 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Academia Sinica and vaccine developer Moderna Inc. have agreed to jointly develop messenger ribonucleic acid (mRNA) technology and cultivate research talent in Taiwan under a five-year strategic partnership announced Thursday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.